We’re delighted to have advised leading private equity house IW Capital with the equity investment into e-pharmacy platform, SimplyMeds.
IW Capital is a leading private equity house which has invested over £100m in buyout and development capital investment to UK companies.
SimplyMeds is an end-to-end digital pharmacy platform which has grown organically over the last five years from a spare room in a surgery to a material player in London and the South East. It is managed by two entrepreneurs with extensive experience in the pharmaceutical industry – one a prescribing pharmacist and one a dentist - who are looking to innovate to improve access to medicines. SimplyMeds serves both private and NHS sectors and aims to be the best provider of simple, reliable and affordable private healthcare online without compromising on patient care. This investment is the first external investment in the company since its inception and will allow the company to accelerate its development and advance its international market potential through an expansion of distribution channels and a comprehensive sales and marketing spend.
Douglas Lidgitt, Investment Director at IW Capital commented:
"It was a pleasure working with EMW once again on this investment for SimplyMeds. We are excited to be part of the growth story of SimplyMeds and this transaction will enable them to grow the business materially in the next five years. EMW continue to be a fantastic legal partner, providing high quality drafting and robust legal advice whilst driving the deal to completion in only 3 weeks."
Faye Meredith, an Associate in our Corporate team, works with IW Capital on a number of their investments. She commented: “It is always a pleasure completing a deal with IW Capital. Our close working relationship means that we can deliver a smooth and efficient service to our client which is always appreciated by the companies that they invest in and we are delighted to have been able to complete this deal in such a tight timescale for all parties. SimplyMeds is a unique investment opportunity for IW Capital and no doubt with their support SimplyMeds can rapidly enhance its market position.”
Get in touch
Our Corporate team advises companies, management teams, investors and debt providers from business start-ups through to mergers and acquisitions, management buyouts, development funding and exit.
For more information about this deal please contact Faye Meredith, or give us a call on 0345 070 6000.